News

  • All
  • Asylia News
  • Nirogy News
  • Press Release
  • Sporos News
  • Stellanova News
  • Tvardi News
Asylia News

JLABS @ TMC and Asylia Therapeutics on Navigating a Powerful Tool: The Human Immune System

Read More →
Nirogy News

Nirogy Therapeutics Launches with $16.5 Million Series A Financing

Read More →
Tvardi News

Tvardi Therapeutics Awarded “Most Promising” Company at the 2020 Texas Life Science Forum

Read More →
Asylia News

New Company Asylia Therapeutics Finalizes Exclusive Worldwide License Agreement

Read More →
Tvardi News

Tvardi Therapeutics Announces Publication Demonstrating TTI-101 as a Therapeutic Option for Treatment-Resistant Breast Cancers

Read More →
Tvardi News

Tvardi’s TTI-101 Receives $5 Million in Funding to Support Clinical Trials and Translational Research

Read More →
Asylia News

Asylia Therapeutics Moves into JLABS @TMC

Read More →
Tvardi News

KRLD Radio Interview: Some Covid Survivors Face Long-Term Consequences

Read More →
Asylia News

CPRIT Awards $3 Million to Asylia Therapeutics

Read More →
Asylia News

Heat Shock Protein-70 (HSP70) is an Essential Component of Anti-Tumor Immunity

Read More →
Tvardi News

Biotech on the Rise

Read More →
Scroll to Top